Current Data and Future Perspectives on Patients with Atrial Fibrillation and Cancer

Current Data and Future Perspectives on Patients with Atrial Fibrillation and Cancer

Atrial fibrillation (AF) is an increasingly recognized comorbidity in patients with cancer. Indeed, cancer patients have a significantly higher incidence of AF than that observed in the general population. A reciprocal relationship between these two diseases has been observed, as much as some assume...

Full description

Bibliographic Details
Main Authors:	Leonardo De Luca, Massimiliano Camilli, Maria Laura Canale, Raffaella Mistrulli, Federico Andreoli, Guido Giacalone, Fabio Maria Turazza, Domenico Gabrielli, Irma Bisceglia
Format:	Article
Language:	English
Published:	MDPI AG 2023-11-01
Series:	Cancers
Subjects:	atrial fibrillation cancer anticoagulation
Online Access:	https://www.mdpi.com/2072-6694/15/22/5357

Similar Items

New oral anticoagulants for atrial fibrillation
by: Yuliana Yakobus
Published: (2017-06-01)

Prevalence of oral anticoagulation in atrial fibrillation
by: Eduardo Bartholomay, et al.
Published: (2014-09-01)

ANTICOAGULATION CONTROL AMONG PATIENTS WITH ATRIAL FIBRILLATION
by: Amer Rauf, et al.
Published: (2020-12-01)

Concerns Regarding the Use of Dabigatran for Stroke Prevention in Atrial Fibrillation
by: Josef Finsterer, et al.
Published: (2012-02-01)

Trajectories of Oral Anticoagulation Adherence Among Medicare Beneficiaries Newly Diagnosed With Atrial Fibrillation
by: Inmaculada Hernandez, et al.
Published: (2019-06-01)

Pharmacologic Therapy in the Elderly with Atrial Fibrillation
by: Shih-Huang Lee, et al.
Published: (2008-03-01)

Evaluation of atrial fibrillation management and cardiovascular risk profile in atrial fibrillation patients: A cross-sectional survey
by: Gediminas Račkauskas, et al.
Published: (2017-01-01)

Mid-Term Feasibility of Percutaneous Left Atrial Appendage Occlusion in Elderly Patients with Non-Valvular Atrial Fibrillation
by: Nobuyuki Fukuda, et al.
Published: (2023-09-01)

Antithrombotic therapy for atrial fibrillation and comorbidities — how to choose the optimal solution?
by: E V Schlyakhto, et al.
Published: (2022-01-01)

Do all patients with atrial fibrillation need long-term anticoagulation?
by: Munish Sharma, et al.
Published: (2017-07-01)

Provider Specialty, Anticoagulation Prescription Patterns, and Stroke Risk in Atrial Fibrillation
by: Wesley T. O'Neal, et al.
Published: (2018-03-01)

Frailty and oral anticoagulant prescription in adults with atrial fibrillation: A systematic review
by: Mary Bul, et al.
Published: (2023-06-01)

Management and Prognosis of Acute Stroke in Atrial Fibrillation
by: Mette F. Hindsholm, et al.
Published: (2023-09-01)

Secondary Precipitants of Atrial Fibrillation and Anticoagulation Therapy
by: Darae Ko, et al.
Published: (2021-11-01)

Atrial fibrillation: non cardiologist physicians approach
by: Forero-Gómez, Julián Eduardo, et al.
Published: (2017-10-01)

Management of Atrial Fibrillation in Older Patients by Morbidity Burden: Insights From Get With The Guidelines‐Atrial Fibrillation
by: Frederik Dalgaard, et al.
Published: (2020-12-01)

Oral anticoagulation to reduce risk of stroke in patients with atrial fibrillation: current and future therapies
by: Amin A
Published: (2013-01-01)

Oral anticoagulant therapy for older patients with atrial fibrillation
by: Mario Bo, et al.
Published: (2017-09-01)

Oral Anticoagulants in Patients with Atrial Fibrillation and Active Cancer
by: Li-Ying Yu, et al.
Published: (2022-06-01)

Characteristics and Treatment of Atrial Fibrillation with Respect to the Presence or Absence of Heart Failure. Insights from the Multicenter Polish Atrial Fibrillation (POL-AF) Registry
by: Monika Gawałko, et al.
Published: (2021-03-01)

Sex Differences in Oral Anticoagulation and Outcomes of Stroke and Intracranial Bleeding in Newly Diagnosed Atrial Fibrillation
by: Celina M. Yong, et al.
Published: (2020-05-01)

Clinical Prediction Model for Time in Therapeutic Range While on Warfarin in Newly Diagnosed Atrial Fibrillation
by: Brent A. Williams, et al.
Published: (2017-10-01)

Management of anticoagulation in atrial fibrillation patients in Italy: insight from the <i>Atrial Fibrillation-Survey on Anticoagulated Patients Register</i> (AF-START)
by: Daniela Poli, et al.
Published: (2023-06-01)

An instrument to measure atrial fibrillation knowledge in Chinese patients: validation of the Jessa Atrial fibrillation Knowledge Questionnaire
by: Sijie Chang, et al.
Published: (2023-06-01)

ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS
by: M. Yu. Gilyarov, et al.
Published: (2016-01-01)

Association of Depression and Adherence to Oral Anticoagulation in Patients With Atrial Fibrillation
by: Matthew E. Lapa, et al.
Published: (2023-11-01)

Stroke Prevention in Atrial Fibrillation: Latest Clinical Trials and Guidelines
by: Luciana Armaganijan, et al.
Published: (2012-04-01)

Lower dementia risk with anticoagulation and ablation in patients with atrial fibrillation
by: Daehoon Kim, et al.
Published: (2021-09-01)

The Importance of Appropriate Dosing of Nonvitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation
by: Jan Beyer-Westendorf, et al.
Published: (2021-07-01)

Anticoagulants in Older Patients with Nonvalvular Atrial Fibrillation after Intracranial Hemorrhage
by: Sylvie Perreault, et al.
Published: (2019-05-01)

THE IMPORTANCE OF EARLY CARDIOVERSION OF PAROXYSMAL ATRIAL FIBRILLATION
by: Franc Verovnik
Published: (2002-01-01)

Net Clinical Benefit of Left Atrial Appendage Closure Versus Warfarin in Patients With Atrial Fibrillation: A Pooled Analysis of the Randomized PROTECT‐AF and PREVAIL Studies
by: Tom F. Brouwer, et al.
Published: (2019-12-01)

Effects of sufficient anticoagulation on ischemic stroke outcomes in patients with nonvalvular atrial fibrillation
by: Tae Jung Kim, et al.
Published: (2023-12-01)

A patient with atrial fibrillation and diabetes: selecting the optimal anticoagulant therapy regimen
by: A. G. Obrezan, et al.
Published: (2021-06-01)

Prescribing Trends of Oral Anticoagulants in US Patients With Cirrhosis and Nonvalvular Atrial Fibrillation
by: Tracey G. Simon, et al.
Published: (2023-02-01)

Direct Oral Anticoagulant Adherence of Patients With Atrial Fibrillation Transitioned from Warfarin
by: Krishna N. Pundi, et al.
Published: (2021-12-01)

Racial and Sex Disparities in Anticoagulation After Electrical Cardioversion for Atrial Fibrillation and Flutter
by: Amgad Mentias, et al.
Published: (2021-09-01)

Natural Course of New‐Onset Postoperative Atrial Fibrillation after Noncardiac Surgery
by: Junho Hyun, et al.
Published: (2021-04-01)

Use of Oral Anticoagulants in Patients with Atrial Fibrillation: Preliminary Data from the Italian Atrial Fibrillation (ITALY-AF) Registry
by: Fabio Angeli, et al.
Published: (2023-09-01)

Anticoagulation for Atrial Fibrillation in Cirrhosis of the Liver: Are Low‐Dose Non‐Vitamin K Oral Anticoagulants a Reasonable Alternative to Warfarin?
by: Celine Gallagher, et al.
Published: (2019-03-01)